{"id":"W2746676535","doi":"10.1007/s10120-017-0754-1","title":"Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Gastric Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Medical Research Council; National Health and Medical Research Council; Bayer","keywords":"Medicine; Regorafenib; Quality of life (healthcare); Randomized controlled trial; Internal medicine; Discontinuation; Physical therapy; Oncology; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006910639,0.0001821921,0.0005361192,0.0003406098,0.0002166422,0.0005270196,0.0001903084,0.0003013926,0.000860767],"category_scores_gemma":[0.002658334,0.00006961013,0.001173957,0.0007328148,0.0002400546,0.0004105369,0.0003743809,0.0007049449,0.00006535629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007177424,"about_ca_system_score_gemma":0.0003554047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002365156,"about_ca_topic_score_gemma":0.004259958,"domain_scores_codex":[0.9995437,0.0001830338,0.00005742721,0.00004186573,0.00008098342,0.00009294318],"domain_scores_gemma":[0.9988688,0.0002823421,0.0005671289,0.00002925529,0.00008071499,0.0001716717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005340895,0.0003459802,0.955187,0.0002572816,0.001446763,0.000311079,0.00009805662,0.0009016714,0.000623257,0.00009901398,0.000682767,0.03470627],"study_design_scores_gemma":[0.00007366093,0.0007805435,0.9973304,0.00002981455,0.0003517981,0.000191749,0.0001254859,0.0004498335,0.00008373171,0.0000832669,0.0004919206,0.000007816434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923983,0.005655186,0.00005114448,0.0003765622,0.00002710934,0.00001261339,0.0003655063,0.000003499533,0.001110029],"genre_scores_gemma":[0.9988256,0.0005555194,0.00003065801,0.00008296987,0.00002669221,0.000006188451,0.0003959817,5.716903e-7,0.00007579917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002365156,"threshold_uncertainty_score":0.005207598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05296989581928377,"score_gpt":0.335803470103708,"score_spread":0.2828335742844242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}